Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,968 public trials 717 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment

NCT00330330

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • NZOZ Specjalistyczny Osrodek Internistyczno Diabetologiczny Bialystok, Poland
  • Prywatna Praktyka Lekarska Radom, Poland
  • Oddzial Chorob Wewnetrznych ze Stacja Dializ Szpital w Wolominie Wołomin, Poland
  • Chair of Endocrinology and Diabetology of the Faculty of Advenced Training for Physicians Moscow, Russia
View Trial Details
Completed

Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)

NCT00099515

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Clearwater, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buffalo, New York, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Hyde Park, New York, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sante Fe, Rosario, Argentina
View Trial Details
Completed

Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus

NCT00102297

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • UCLA - LA BioMed Los Angeles, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Radiant Research Dallas, Texas, United States
  • Diabetes & Glandular Disease San Antonio, Texas, United States
View Trial Details

Related conditions